Gefitinib-Sensitive EGFR Lacking Residues 746–750 Exhibits Hypophosphorylation at Tyrosine Residue 1045, Hypoubiquitination, And Impaired Endocytosis.

Autor: Furukawa, Mitsugi, Nagatomo, Izumi, Kumagai, Toru, Yamadori, Tadahiro, Takahashi, Ryo, Yoshimura, Mana, Yoneda, Tsutomu, Takeda, Yoshito, Goya, Sho, Matsuoka, Hiroto, Kijima, Takashi, Yoshida, Mitsuhiro, Osaki, Tadashi, Tachibana, Isao, Greene, Mark I., Kawase, Ichiro
Předmět:
Zdroj: DNA & Cell Biology; Mar2007, Vol. 26 Issue 3, p178-185, 8p, 5 Black and White Photographs
Abstrakt: Gefitinib-sensitive nonsmall cell lung cancers (NSCLC) are characterized by somatic mutations in the kinase domain of epidermal growth factor receptor (EGFR). The mutant EGFR forms are reported to mediate characteristic signal transduction pathways that are different from those mediated by the wild-type EGFR and are involved in transformation in vivo. We have examined signal transduction pathways initiated from a frequently identified gefitinib-sensitizing mutant EGFR lacking residues 746–750 by employing a mouse fibroblast cell line that is free of endogenous EGFR and transiently transfected COS-7 cells. Upon EGF stimulation, the deletion-mutant EGFR mediated prolonged downstream signals. The analysis of the phosphotyrosine patterns of the receptor revealed that the deletion-mutant EGFR lacked phosphorylation at tyrosine residue 1045, which is the major binding site of Cbl. The EGF-induced endocytosis of the deletion-mutant EGFR was impaired. The ubiquitination and downregulation of the deletion-mutant EGFR were also reduced. On the other hand, another mutant, EGFR, possessing a L858R substitution, exhibited phosphorylation at 1045 and its downstream signalings were not prolonged. These data suggest that the signal transduction pathways initiated from these mutant forms are different, and that impaired endocytosis might be responsible for the prolonged signals mediated by the deletion-mutant EGFR. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index